LB PHARMACEUTICALS INC 8-K

What Happened

• LB Pharmaceuticals Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release dated May 12, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02: Results of Operations and Financial Condition) filed on May 12, 2026. The Form 8‑K also includes Inline XBRL cover page tags (Exhibit 104).

Key Details

• Filing date: May 12, 2026; press release furnished as Exhibit 99.1.
• Period covered: quarter ended March 31, 2026 (quarterly results / earnings disclosure).
• Form 8‑K Item: 2.02 — Results of Operations and Financial Condition.
• Technical exhibit: Exhibit 104 (Cover Page Interactive Data File with Inline XBRL tags) included.

Why It Matters

• This 8‑K is the company’s timely disclosure of its quarterly results (earnings, revenue and other operating metrics will be in the press release). Retail investors should read Exhibit 99.1 to see the reported revenue, net income (or loss), and any commentary on trends or guidance.
• The Form 8‑K itself does not replace periodic filings (such as the upcoming 10‑Q) but provides immediate access to the company’s quarterly results and management statements, which can affect near‑term investor decisions.